Opinion|Videos|May 3, 2024

Overcoming Limitations and Barriers Associated with Treating Pulmonary Arterial Hypertension

An expert on pulmonary arterial hypertension discusses the limitations of current therapies and the barriers to early diagnosis.

Video content above is prompted by the following questions:

  • What are the limitations of current pulmonary arterial hypertension (PAH) therapies that primarily focus on symptom management, and how do they impact patient outcomes?
  • How does the high disease burden associated with PAH affect patients' quality of life and functional status?
  • What are the barriers to early diagnosis and initiation of treatment for PAH, and how do they contribute to poor outcomes?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo